Zobrazeno 1 - 10
of 95
pro vyhledávání: '"Ranimustine"'
Autor:
Tomoaki Tanaka, Kentaro Horiguchi, Sawako Suzuki, Kazuki Ishiwata, Hanna Deguchi-Horiuchi, Naoko Inoshita, Masanori Fujimoto, Chikako Ohwada, Yasuo Iwadate, Emiko Sakaida, Akiko Ishida, Ichiro Tatsuno, Yutaro Ruike, Kumiko Naito, Hisashi Koide, Jun-ichiro Ikeda, Koutaro Yokote
Publikováno v:
AACE Clinical Case Reports
Objective Intravascular large B-cell lymphoma (IVLBCL) is a rare and aggressive type of B-cell lymphoma with large cells growing within the lumen of blood vessels. Although previous reports revealed highly variable symptoms resulting from small-vesse
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::99771fa51850170f6edd9557d5c05b69
https://doi.org/10.1016/j.aace.2021.01.011
https://doi.org/10.1016/j.aace.2021.01.011
Autor:
Kunihiro Tsukasaki, Kisato Nosaka, Junji Tanaka, Kenji Ishitsuka, Kaoru Uchimaru, Yoshitaka Imaizumi, for collaborative Investigators, Masako Iwanaga, Masahiro Amano, Toshiki Watanabe, Kenichi Ishizawa, Koichi Ohshima, Naokuni Uike, Atae Utsunomiya, Yoshiki Tokura, Kensei Tobinai, Takashi Ishida, Shigeki Ito
Publikováno v:
Cancer Science
Adult T‐cell leukemia/lymphoma (ATL) is a mature T‐cell neoplasm and is classified into four subtypes (acute, lymphoma, chronic, and smoldering) according to the Shimoyama classification, established in 1991 through several nationwide surveys bas
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ebde724bbadab139ebcc704bc731130c
https://doi.org/10.1111/cas.14658
https://doi.org/10.1111/cas.14658
Publikováno v:
International Journal of Hematology. 111:434-439
The outcome of relapsed/refractory HIV-associated lymphoma remains poor, even in the era of combined antiretroviral therapy. However, recent reports showed the efficacy of autologous stem cell transplantation (ASCT). We conducted a single-arm, multic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::40953db29b2722d9dd93d2be274e3c9e
https://doi.org/10.1007/s12185-019-02791-y
https://doi.org/10.1007/s12185-019-02791-y
Autor:
Ryunosuke Machida, Hirokazu Nagai, Kosuke Toyoda, Kenji Ishitsuka, Dai Maruyama, Kunihiro Tsukasaki, Takuya Fukushima, Tomohiro Kadota
Publikováno v:
British Journal of Haematology. 186:440-447
JCOG9801, a randomized phase III trial, reported that vincristine, cyclophosphamide, doxorubicin and prednisone (VCAP); doxorubicin, ranimustine and prednisone (AMP); and vindesine, etoposide, carboplatin and prednisone (VECP) (VCAP-AMP-VECP; mLSG15)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::474765bb45463e1542e776176440d1f3
https://doi.org/10.1111/bjh.15950
https://doi.org/10.1111/bjh.15950
Autor:
Tadakazu Kondo, Akifumi Takaori-Kondo, Takero Shindo, Masakatsu Hishizawa, Momoko Nishikori, Mitsumasa Watanabe, Fumiya Wada, Akiko Aiba, Toshiyuki Kitano, Yayoi Shimazu
Publikováno v:
International journal of hematology. 112(5)
Autologous stem cell transplantation (ASCT) with high-dose thiotepa and busulfan is a treatment option for patients with central nervous system (CNS) lymphoma. We report here the occurrence of secondary failure of platelet recovery (SFPR) in three ou
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d4fa3362c22100795d15ae909bdc9ebb
https://pubmed.ncbi.nlm.nih.gov/32980953
https://pubmed.ncbi.nlm.nih.gov/32980953
Autor:
Tomoaki Akagi, Shigeki Ito, Kazunori Murai, Hideo Harigae, Hideyoshi Noji, Yuichi Kato, Osamu Sasaki, Yoji Ishida, Yoshihiro Kameoka, Kenichi Ishizawa, Ryo Ichinohasama, Naoto Takahashi
Publikováno v:
International Journal of Hematology. 108:510-515
High-dose chemotherapy followed by autologous stem cell transplantation (ASCT) is widely used as a salvage therapy for relapsed or high-risk diffuse large B-cell lymphoma (DLBCL). To investigate the safety and efficacy of regimens including high-dose
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::efddce30d849b99b2843a7ad5834db74
https://doi.org/10.1007/s12185-018-2508-1
https://doi.org/10.1007/s12185-018-2508-1
Autor:
Naomi Katsumata, Hidekazu Arai, Osamu Imataki, Tetsuo Kume, Takashi Aoyama, Keiko Ishide, Hitomi Shiozaki, Takashi Ikeda, Mariko Mori
Publikováno v:
Medical Science Monitor Basic Research
BACKGROUND The aim of this study was to compare nutrition-related adverse events and clinical outcomes of ifosfamide, carboplatin, and etoposide regimen (ICE therapy) and ranimustine, carboplatin, etoposide, and cyclophosphamide regimen (MCEC therapy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d4e5d6c08de1eb9c4c9c10965b2ee830
https://doi.org/10.12659/msmbr.908113
https://doi.org/10.12659/msmbr.908113
Autor:
Achiléa L. Bittencourt, Ítala Gomes, Gloria Bomfim Arruda, Pedro D. Oliveira, Victor Hugo Gomes Souza, Ernesto Cunha Pires
Publikováno v:
Revista Brasileira de Hematologia e Hemoterapia, Vol 39, Iss 1, Pp 13-19
Revista Brasileira de Hematologia e Hemoterapia, Volume: 39, Issue: 1, Pages: 13-19, Published: MAR 2017
Revista Brasileira de Hematologia e Hemoterapia v.39 n.1 2017
Revista brasileira de hematologia e hemoterapia
Associação Brasileira de Hematologia e Hemoterapia e Terapia Celular (ABHHTC)
instacron:ABHHTC
Revista Brasileira de Hematologia e Hemoterapia
Revista Brasileira de Hematologia e Hemoterapia, Volume: 39, Issue: 1, Pages: 13-19, Published: MAR 2017
Revista Brasileira de Hematologia e Hemoterapia v.39 n.1 2017
Revista brasileira de hematologia e hemoterapia
Associação Brasileira de Hematologia e Hemoterapia e Terapia Celular (ABHHTC)
instacron:ABHHTC
Revista Brasileira de Hematologia e Hemoterapia
Background Adult T-cell leukemia/lymphoma is a peripheral disease associated with human T-cell lymphotropic virus type 1. Treatment is carried out according to clinical type with watchful waiting being recommended for less aggressive types. Aggressiv
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::86cf2e4291a9bcfe01b418497a79ac2c
Publikováno v:
International journal of hematology. 112(2)
Acute myeloid leukemia (AML) harboring Fms-like tyrosine kinase 3 (FLT3) internal tandem duplication (ITD) mutation is associated with shorter remission and higher relapse risk. Several FLT3 inhibitors have been used in clinical trials, but their eff
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::01cb438b90ca99f26620f70d0500a08f
https://pubmed.ncbi.nlm.nih.gov/32170661
https://pubmed.ncbi.nlm.nih.gov/32170661
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 16:S191-S194
Background Adult T-cell leukemia/lymphoma (ATLL) is aggressive mature T-cell lymphoproliferative disorder with a poor outcome. Methods We present 10 patients with acute and lymphomatous subtypes of ATLL treated with distinct induction regimens, inclu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2cfba2b081f76bb2dadbd17f80a2236c
https://doi.org/10.1016/j.clml.2016.02.010
https://doi.org/10.1016/j.clml.2016.02.010